Japan approves BioCryst's Orladeyo for children ages 2 to 12 with HAE
Go back to Japan approves BioCryst's Orladeyo for children ages 2 to 12 with HAE| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 9.06 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.06 | 52 Week High | $10.98 | |||
| Open | $9.06 | 52 Week Low | $1.63 | |||
| Day High | $9.06 | P/E | N/A | |||
| Day Low | $9.06 | EPS | $-0.68 | |||
| Volume | 4,625 | |||||
